Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Avara Liscate Pharmaceutical Services SPA
FDA Inspection
•Avara Liscate Pharmaceutical Services SPA•May 13, 2014

Avara Liscate Pharmaceutical Services SPA – FDA Inspection, May 13, 2014

Record Details

This FDA Inspection record concerns Avara Liscate Pharmaceutical Services SPA, with an inspection on May 13, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Avara Liscate Pharmaceutical Services SPA
Inspection Date
May 13, 2014
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 0b045d21-f7bf-444f-a371-de663c5b0b4d

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
881210
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

10
  1. 21 CFR 211.68(b)Computer control of master formula records
  2. 21 CFR 211.42(c)(10)(v)Cleaning System
  3. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  4. 21 CFR 211.160(a)Following/documenting laboratory controls
  5. 21 CFR 211.194(a)Complete test data included in records
  6. 21 CFR 211.113(b)Validation lacking for sterile drug products
  7. 21 CFR 211.170(b)Annual visual exams of drug products
  8. 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
  9. 21 CFR 211.42(c)Defined areas of adequate size for operations
  10. 21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Avara Liscate Pharmaceutical Services SPA

5
DateClassificationOfficeProject area
June 9, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 6, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 20, 2019VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
November 22, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 9, 2011NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Avara Liscate Pharmaceutical Services SPA
  • FDA Inspection 1244256 - 2023-06-09
  • FDA Inspection 1192062 - 2022-12-06
  • FDA Inspection 1102380 - 2019-09-20
  • FDA Inspection 1000021 - 2016-11-22
  • FDA Inspection 754834 - 2011-11-09

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avara Liscate Pharmaceutical Services SPA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.